Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment.
Bachurin SO, Shevtsova EF, Makhaeva GF, Grigoriev VV, Boltneva NP, Kovaleva NV, Lushchekina SV, Shevtsov PN, Neganova ME, Redkozubova OM, Bovina EV, Gabrelyan AV, Fisenko VP, Sokolov VB, Aksinenko AY, Echeverria V, Barreto GE, Aliev G. Bachurin SO, et al. Among authors: echeverria v. Sci Rep. 2017 Mar 30;7:45627. doi: 10.1038/srep45627. Sci Rep. 2017. PMID: 28358144 Free PMC article.
Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease.
Jurado-Coronel JC, Ávila-Rodriguez M, Echeverria V, Hidalgo OA, Gonzalez J, Aliev G, Barreto GE. Jurado-Coronel JC, et al. Among authors: echeverria v. CNS Neurol Disord Drug Targets. 2016;15(3):292-300. doi: 10.2174/1871527315666160202125519. CNS Neurol Disord Drug Targets. 2016. PMID: 26831259
Microglial dependent protective effects of neuroactive steroids.
Lanussa OH, Ávila-Rodriguez M, García-Segura LM, González J, Echeverria V, Aliev G, Barreto GE. Lanussa OH, et al. Among authors: echeverria v. CNS Neurol Disord Drug Targets. 2016;15(2):242-9. doi: 10.2174/1871527315666160202122032. CNS Neurol Disord Drug Targets. 2016. PMID: 26831265 Review.
100 results